Skip to main content

Table 2

From: Differential regulation of CCL-11/eotaxin-1 and CXCL-8/IL-8 by Gram-positive and Gram-negative bacteria in human airway smooth muscle cells

Treatments Concentrations Mean ± s.e.m
control 0 248.3 ± 76.44
S. aureus (CFU ml-1) 106 328.8 ± 132.1
  107 170.0 ± 56.09
  108 2564 ± 1062
PAM 3 (ng ml-1) 3 405.3 ± 103.0
  30 2108 ± 531.5
  300 7994 ± 2178.0
FSL1 (ng ml-1) 10 370.6 ± 144.4
  100 509.0 ± 214.4
  1000 3792 ± 1379
MDPLys18 (10 nM) 10 218.1 ± 95.11
  100 444.1 ± 143.1
  1. Effect of Gram-positive bacteria and associated PAMPs on CXCL-8 release from human ASMCs over 48 h. ASMCs were treated either Gram-positive bacteria S. aureus, (106–108 CFU ml-1), Pam3CSK4 (3 – 300 ng ml-1), FSL-1, (10 – 1000 ng ml-1) or MDPLys18 (10 nM and 100 nM). The data represent the mean ± SEM of triplicate of three different donors.